Reports of Patent, Design, and Trade Mark Cases, Issues 1-5; Issues 8-13Published at the Patent Office Sales Branch, 2003 - Industrial property |
From inside the book
Results 1-3 of 69
Page 119
... sufficient to work the invention . Other decisions of the EPO seem to me to make it clear that , at least for some purposes , products need not be known under their chemical description in order to be part of the state of the art . In ...
... sufficient to work the invention . Other decisions of the EPO seem to me to make it clear that , at least for some purposes , products need not be known under their chemical description in order to be part of the state of the art . In ...
Page 260
... sufficiently long , there will be sufficient mixing within it to enable complete combustion . The other way is by use of a Venturi tube . Such a tube typically has a narrowing or throat such that on either side of the throat the walls ...
... sufficiently long , there will be sufficient mixing within it to enable complete combustion . The other way is by use of a Venturi tube . Such a tube typically has a narrowing or throat such that on either side of the throat the walls ...
Page 412
... sufficient as consideration had to be given to their anxieties and legitimate expectations . ( para . [ 32 ] ) Barrell Enterprises ( In Re ) [ 1973 ] 1 W.L.R. 19 , CA and Stewart v Engel [ 2000 ] 1 W.L.R. 2268 , CA referred to . ( 3 ) ...
... sufficient as consideration had to be given to their anxieties and legitimate expectations . ( para . [ 32 ] ) Barrell Enterprises ( In Re ) [ 1973 ] 1 W.L.R. 19 , CA and Stewart v Engel [ 2000 ] 1 W.L.R. 2268 , CA referred to . ( 3 ) ...
Other editions - View all
Common terms and phrases
ALBERTA FERRETTI amendment Amgen amino acid Appointed Person Arsenal FC Arsenal Football Club burner cell claim 19 claimant colour common general knowledge contact lens CooperVision Court of Appeal cross-examination Davies decision defendants Directive distinctive character DNA sequence dots earlier trade mark effect erythropoietin European Patent evidence filed gene hearing officer High Court Inc v Transkaryotic infringement Integer inventive step iris section issue judge judgment Kirin-Amgen Inc lenses likelihood of confusion Ltd's Trade Mark Marks Act 1994 Meneghetti non-use opponent paragraph numbers paras Patent Office Philips Electronics NV Plc v Reed prior art priority date protein question Quickfit reason Reed Business Information referred registered trade mark registrar relation relevant Remington Consumer Products revocation shape Silverleaf specification submissions Sweet & Maxwell Synthon third party TORRES TRADE MARK 2003 Trade Mark Application trade mark proprietor Trade Marks Act Transkaryotic Therapies Inc uEPO United Kingdom word